DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription factor dysregulation in chronic lymphocytic leukemia (CLL). By comparing normal and malignant B cells, they find that tumors derive from a co...
Saved in:
Published in | Nature genetics Vol. 48; no. 3; pp. 253 - 264 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.03.2016
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription factor dysregulation in chronic lymphocytic leukemia (CLL). By comparing normal and malignant B cells, they find that tumors derive from a continuum of maturation states, which correlate with different clinical outcomes.
Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program. |
---|---|
AbstractList | Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program. Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program. Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription factor dysregulation in chronic lymphocytic leukemia (CLL). By comparing normal and malignant B cells, they find that tumors derive from a continuum of maturation states, which correlate with different clinical outcomes. Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program. |
Audience | Academic |
Author | Kipps, Thomas J Plass, Christoph Stilgenbauer, Stephan Byrd, John C Döhner, Hartmut Mertens, Daniel Assenov, Yassen Küppers, Ralf Gu, Lei Koser, Sandra D Imbusch, Charles D Bogatyrova, Olga Lipka, Daniel B Rassenti, Laura Seifert, Marc Weichenhan, Dieter Ruppert, Amy S Serva, Andrius Zapatka, Marc Przekopowitz, Martina Zenz, Thorsten Wang, Qi Brocks, David Lichter, Peter Oakes, Christopher C Brors, Benedikt |
AuthorAffiliation | 2 Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany 7 Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany 5 Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA 10 Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany 8 Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany 1 Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany 4 Division of Newborn Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA 6 Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany 11 Department of Internal Medicine III, University of Ulm, Ulm, Germany 3 Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA 9 Department of Medicine, University of California at San Diego Moo |
AuthorAffiliation_xml | – name: 3 Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA – name: 11 Department of Internal Medicine III, University of Ulm, Ulm, Germany – name: 1 Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 7 Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 10 Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 4 Division of Newborn Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA – name: 13 Department of Medicine V, University of Heidelberg, Heidelberg, Germany – name: 5 Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA – name: 8 Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 12 Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 2 Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany – name: 6 Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 9 Department of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, California, USA |
Author_xml | – sequence: 1 givenname: Christopher C surname: Oakes fullname: Oakes, Christopher C email: christopher.oakes@osumc.edu organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Present address: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA – sequence: 2 givenname: Marc surname: Seifert fullname: Seifert, Marc organization: Institute of Cell Biology (Cancer Research), University of Duisburg-Essen – sequence: 3 givenname: Yassen surname: Assenov fullname: Assenov, Yassen organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) – sequence: 4 givenname: Lei surname: Gu fullname: Gu, Lei organization: Department of Cell Biology, Harvard Medical School, Division of Newborn Medicine, Boston Children's Hospital – sequence: 5 givenname: Martina surname: Przekopowitz fullname: Przekopowitz, Martina organization: Institute of Cell Biology (Cancer Research), University of Duisburg-Essen – sequence: 6 givenname: Amy S surname: Ruppert fullname: Ruppert, Amy S organization: Division of Hematology, Department of Internal Medicine, The Ohio State University – sequence: 7 givenname: Qi surname: Wang fullname: Wang, Qi organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) – sequence: 8 givenname: Charles D surname: Imbusch fullname: Imbusch, Charles D organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) – sequence: 9 givenname: Andrius surname: Serva fullname: Serva, Andrius organization: Division of Molecular Genetics, German Cancer Research Center (DKFZ) – sequence: 10 givenname: Sandra D surname: Koser fullname: Koser, Sandra D organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) – sequence: 11 givenname: David surname: Brocks fullname: Brocks, David organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) – sequence: 12 givenname: Daniel B surname: Lipka fullname: Lipka, Daniel B organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) – sequence: 13 givenname: Olga surname: Bogatyrova fullname: Bogatyrova, Olga organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) – sequence: 14 givenname: Dieter surname: Weichenhan fullname: Weichenhan, Dieter organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) – sequence: 15 givenname: Benedikt surname: Brors fullname: Brors, Benedikt organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) – sequence: 16 givenname: Laura surname: Rassenti fullname: Rassenti, Laura organization: Department of Medicine, University of California at San Diego Moores Cancer Center – sequence: 17 givenname: Thomas J surname: Kipps fullname: Kipps, Thomas J organization: Department of Medicine, University of California at San Diego Moores Cancer Center – sequence: 18 givenname: Daniel surname: Mertens fullname: Mertens, Daniel organization: Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Department of Internal Medicine III, University of Ulm – sequence: 19 givenname: Marc surname: Zapatka fullname: Zapatka, Marc organization: Division of Molecular Genetics, German Cancer Research Center (DKFZ) – sequence: 20 givenname: Peter surname: Lichter fullname: Lichter, Peter organization: Division of Molecular Genetics, German Cancer Research Center (DKFZ), Present address: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA – sequence: 21 givenname: Hartmut surname: Döhner fullname: Döhner, Hartmut organization: Department of Internal Medicine III, University of Ulm – sequence: 22 givenname: Ralf surname: Küppers fullname: Küppers, Ralf organization: Institute of Cell Biology (Cancer Research), University of Duisburg-Essen – sequence: 23 givenname: Thorsten surname: Zenz fullname: Zenz, Thorsten organization: Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Department of Medicine V, University of Heidelberg – sequence: 24 givenname: Stephan surname: Stilgenbauer fullname: Stilgenbauer, Stephan organization: Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ) – sequence: 25 givenname: John C surname: Byrd fullname: Byrd, John C organization: Division of Hematology, Department of Internal Medicine, The Ohio State University – sequence: 26 givenname: Christoph orcidid: 0000-0003-2554-3952 surname: Plass fullname: Plass, Christoph email: c.plass@dkfz.de organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26780610$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl2L1DAUhousuB-K_0ACXqgXHZNN0mZuhHH9Wlhc8Os2pOlpJ2ub1CQVC_54U2dWd0ZBCSQh58nL4T3vcXZgnYUsu0_wgmAqntp2QZkQt7IjwlmRk5KIg3THBckZpsVhdhzCFcaEMSzuZIenRSlSDR9l31-8XaEe4nrqVDTOonqyqjc6oHr0xrboOdLQdahXcfQbYrQ1-M4AUkg7G40dxx65BtUmgAqAhjVYF6cBAjIW6bV31mjUTf2wdnqK8x3Gz9AbdTe73aguwL3teZJ9fPXyw9mb_OLy9fnZ6iLXJWUx7Urx5rRiBSesJrTSpNJcY1U3tKkElJWiitZ8iVnNOaUUU0oYL3GheSlgSU-yZxvdYax6qDXY6FUnB2965SfplJG7FWvWsnVfJVsWFGOeBB5vBbz7MkKIsjdh9kVZcGOQRGBRMkyW9N9oWQhSlASzhD7cQ6_c6G1yIlFlGuuScfqbalUH0tjGpRb1LCpXjBVEsJKRRC3-QqVVJ6PTmKAx6X3nw5OdD_Mo4Vts1RiCPH__7v_Zy0-77IObXv8y-TpyCcg3gPYuBA-N1Cb-TFbq2HSSYDlHWtpWzpFO_KM9_lryT3JrfRjm6IK_4ece-gOQUgGI |
CitedBy_id | crossref_primary_10_1182_bloodadvances_2024013327 crossref_primary_10_1007_s10528_018_9841_1 crossref_primary_10_1002_ajh_26367 crossref_primary_10_1080_10428194_2024_2438804 crossref_primary_10_1371_journal_pone_0208753 crossref_primary_10_15252_msb_20178124 crossref_primary_10_3389_fonc_2019_00079 crossref_primary_10_1158_2643_3230_BCD_20_0207 crossref_primary_10_15252_embr_202256420 crossref_primary_10_1172_JCI93801 crossref_primary_10_1007_s13205_024_04133_0 crossref_primary_10_3324_haematol_2021_278477 crossref_primary_10_1016_j_celrep_2019_10_106 crossref_primary_10_1038_s41392_023_01528_y crossref_primary_10_3390_biomedicines11092335 crossref_primary_10_6004_jnccn_2020_7623 crossref_primary_10_1038_s41586_019_1198_z crossref_primary_10_1126_sciimmunol_aau7523 crossref_primary_10_1080_14728222_2017_1370454 crossref_primary_10_1093_nargab_lqae181 crossref_primary_10_1111_imr_12733 crossref_primary_10_3389_fbioe_2022_842019 crossref_primary_10_1155_2020_7084268 crossref_primary_10_1182_hematology_2019000367 crossref_primary_10_1007_s12032_022_01737_5 crossref_primary_10_1016_j_ccell_2016_03_009 crossref_primary_10_1101_gr_269233_120 crossref_primary_10_1126_scitranslmed_abc4834 crossref_primary_10_1002_art_40877 crossref_primary_10_1002_gcc_22687 crossref_primary_10_1186_s13293_018_0213_7 crossref_primary_10_1186_s12935_021_02266_3 crossref_primary_10_2217_epi_2016_0064 crossref_primary_10_18632_oncotarget_27080 crossref_primary_10_1186_s13073_020_00724_7 crossref_primary_10_1158_2159_8290_CD_20_1202 crossref_primary_10_52547_rbmb_10_3_455 crossref_primary_10_1016_j_coi_2020_09_004 crossref_primary_10_1080_15592294_2020_1834921 crossref_primary_10_1111_bph_13949 crossref_primary_10_1053_j_seminhematol_2023_11_005 crossref_primary_10_1111_bjh_15757 crossref_primary_10_1038_s43018_020_00132_1 crossref_primary_10_1002_ijc_31057 crossref_primary_10_29296_24999490_2024_06_03 crossref_primary_10_1038_s41467_022_29450_x crossref_primary_10_1093_nargab_lqab121 crossref_primary_10_1111_bjh_18465 crossref_primary_10_1002_ajh_27546 crossref_primary_10_3390_diagnostics11050853 crossref_primary_10_1186_s13148_016_0274_6 crossref_primary_10_1016_j_semcancer_2017_09_008 crossref_primary_10_1007_s00438_016_1264_2 crossref_primary_10_3389_fimmu_2018_02720 crossref_primary_10_1158_1535_7163_MCT_15_0685 crossref_primary_10_1158_2159_8290_CD_20_1334 crossref_primary_10_1371_journal_pcbi_1009323 crossref_primary_10_1038_s41591_018_0028_4 crossref_primary_10_1038_s41416_020_01117_8 crossref_primary_10_3892_ol_2024_14685 crossref_primary_10_2217_epi_2018_0020 crossref_primary_10_1146_annurev_pathmechdis_051122_100856 crossref_primary_10_1158_2643_3230_BCD_21_0098 crossref_primary_10_1093_bioinformatics_bty644 crossref_primary_10_1101_cshperspect_a035220 crossref_primary_10_3389_fonc_2021_790004 crossref_primary_10_1089_omi_2018_0206 crossref_primary_10_1016_j_ccell_2016_09_014 crossref_primary_10_1182_blood_2020010029 crossref_primary_10_3390_epigenomes6030028 crossref_primary_10_1038_s41467_022_30050_y crossref_primary_10_3390_cancers12030629 crossref_primary_10_1002_ajh_24301 crossref_primary_10_1159_000487868 crossref_primary_10_1101_cshperspect_a026740 crossref_primary_10_1016_j_semcancer_2017_08_008 crossref_primary_10_1016_j_semcancer_2020_08_004 crossref_primary_10_1182_blood_2015_12_687814 crossref_primary_10_1002_ijc_31999 crossref_primary_10_1038_s41388_020_01549_9 crossref_primary_10_1182_blood_2020010036 crossref_primary_10_1182_bloodadvances_2018024059 crossref_primary_10_1016_j_coi_2018_09_020 crossref_primary_10_1016_j_ebiom_2021_103559 crossref_primary_10_3389_fimmu_2020_01766 crossref_primary_10_3389_fonc_2023_1146486 crossref_primary_10_1016_j_beha_2016_09_003 crossref_primary_10_1016_j_bneo_2024_100059 crossref_primary_10_1111_imm_13207 crossref_primary_10_1182_blood_2022015854 crossref_primary_10_3389_fonc_2023_1248964 crossref_primary_10_1038_s43018_021_00216_6 crossref_primary_10_37349_etat_2024_00253 crossref_primary_10_1038_s41598_020_66224_1 crossref_primary_10_1016_j_smim_2019_101323 crossref_primary_10_1002_hon_2725 crossref_primary_10_1080_15592294_2022_2050004 crossref_primary_10_3324_haematol_2020_251561 crossref_primary_10_1182_blood_2023023797 crossref_primary_10_1186_s12864_017_4117_4 crossref_primary_10_1016_j_biochi_2024_07_006 crossref_primary_10_3390_cancers14030830 crossref_primary_10_1038_nrg_2016_93 crossref_primary_10_3892_ol_2017_5725 crossref_primary_10_1038_s41388_021_01923_1 crossref_primary_10_15252_msb_202110855 crossref_primary_10_1111_imr_13045 crossref_primary_10_3390_cells12192392 crossref_primary_10_1371_journal_pone_0185940 crossref_primary_10_56875_2589_0646_1117 crossref_primary_10_1002_path_6410 crossref_primary_10_1093_hmg_ddy094 crossref_primary_10_1007_s00438_017_1298_0 crossref_primary_10_3390_cancers16061095 crossref_primary_10_15252_msb_20188339 crossref_primary_10_1158_1078_0432_CCR_20_3184 crossref_primary_10_1016_j_biopha_2017_12_059 crossref_primary_10_1038_s41467_018_03025_1 crossref_primary_10_1182_blood_2016_03_707786 crossref_primary_10_1016_j_molimm_2017_11_014 crossref_primary_10_1182_bloodadvances_2019000817 crossref_primary_10_1016_S2152_2650_21_01241_6 crossref_primary_10_1016_j_beha_2023_101513 crossref_primary_10_3324_haematol_2019_236000 crossref_primary_10_3389_fgene_2022_1056043 crossref_primary_10_1002_ijc_30905 crossref_primary_10_1182_blood_2020008311 crossref_primary_10_3390_ijms22179337 crossref_primary_10_1038_leu_2016_359 crossref_primary_10_3390_genes7120125 crossref_primary_10_1186_s13148_019_0783_1 crossref_primary_10_1097_HS9_0000000000000334 crossref_primary_10_1177_11772719211067972 crossref_primary_10_7554_eLife_73754 crossref_primary_10_1038_s41525_017_0010_y crossref_primary_10_1038_s41598_020_57919_6 crossref_primary_10_1016_j_semcancer_2018_02_001 crossref_primary_10_1080_10428194_2022_2153359 crossref_primary_10_1186_s13045_021_01032_2 crossref_primary_10_1146_annurev_pathmechdis_012419_032810 crossref_primary_10_3390_cancers13143587 crossref_primary_10_1038_s41588_022_01140_w crossref_primary_10_3390_epigenomes8030032 crossref_primary_10_1038_s41467_021_25403_y crossref_primary_10_1111_bjh_14719 crossref_primary_10_1016_j_mrfmmm_2017_11_001 crossref_primary_10_1093_nar_gkab322 crossref_primary_10_1186_s43042_023_00411_3 crossref_primary_10_1038_s41556_023_01114_y crossref_primary_10_1038_nm_4410 crossref_primary_10_15252_emmm_201607180 crossref_primary_10_1200_JCO_2016_71_0822 crossref_primary_10_1534_g3_117_300446 crossref_primary_10_3324_haematol_2019_240721 crossref_primary_10_3324_haematol_2022_281869 crossref_primary_10_1182_blood_2019000490 crossref_primary_10_1182_blood_2017_10_764373 crossref_primary_10_1038_s41467_021_26400_x crossref_primary_10_1007_s11912_019_0819_x crossref_primary_10_1182_blood_2018_11_844688 crossref_primary_10_1158_2643_3230_BCD_19_0058 crossref_primary_10_1016_j_jid_2019_05_011 crossref_primary_10_1007_s40142_019_00178_3 crossref_primary_10_3389_fonc_2022_897280 crossref_primary_10_1016_j_jid_2016_11_029 crossref_primary_10_1038_leu_2017_177 crossref_primary_10_1016_j_hoc_2021_03_002 crossref_primary_10_1016_j_hoc_2021_03_004 crossref_primary_10_1182_blood_2018_02_692970 crossref_primary_10_3389_fimmu_2023_1308378 crossref_primary_10_1111_joim_13423 crossref_primary_10_1016_j_sjbs_2017_11_036 crossref_primary_10_1093_hmg_ddaa147 crossref_primary_10_1186_s13073_021_00837_7 crossref_primary_10_1038_s41467_022_32052_2 crossref_primary_10_1182_blood_2018_03_842088 crossref_primary_10_1038_s41467_022_29625_6 crossref_primary_10_1007_s00438_016_1254_4 crossref_primary_10_1186_s12943_025_02260_7 crossref_primary_10_1080_08830185_2021_1964498 crossref_primary_10_1093_bioinformatics_btz327 crossref_primary_10_1038_s41375_020_0846_5 crossref_primary_10_1074_mcp_RA117_000539 crossref_primary_10_1038_ncomms14175 crossref_primary_10_1038_s43018_020_00131_2 crossref_primary_10_1172_JCI138833 crossref_primary_10_1038_s41467_019_14081_6 crossref_primary_10_1002_gcc_22672 crossref_primary_10_1186_s12859_020_3455_4 crossref_primary_10_1182_blood_2018_09_835389 crossref_primary_10_3389_fonc_2023_1143811 crossref_primary_10_3389_fimmu_2018_00683 crossref_primary_10_3390_genes11010110 crossref_primary_10_1038_s41467_017_02177_w crossref_primary_10_1039_C6CS00599C crossref_primary_10_1038_s41467_020_20849_y crossref_primary_10_1038_nrdp_2016_96 crossref_primary_10_1038_s41576_024_00760_8 crossref_primary_10_1186_s13072_018_0252_7 crossref_primary_10_1038_s41598_022_19087_7 crossref_primary_10_1101_gr_277298_122 crossref_primary_10_20517_cdr_2023_98 crossref_primary_10_3389_fonc_2021_651057 crossref_primary_10_1038_leu_2016_230 crossref_primary_10_1111_febs_14934 crossref_primary_10_1038_leu_2016_356 crossref_primary_10_1038_leu_2016_226 crossref_primary_10_1016_j_ccell_2018_11_013 crossref_primary_10_1111_bjh_17193 crossref_primary_10_1038_s41467_022_34642_6 crossref_primary_10_1038_s41467_022_33385_8 crossref_primary_10_1182_blood_2023022180 crossref_primary_10_1182_bloodadvances_2019000367 crossref_primary_10_1016_j_molmed_2021_07_012 crossref_primary_10_1038_nrc_2017_121 crossref_primary_10_18632_oncotarget_20081 crossref_primary_10_3390_cancers14030663 crossref_primary_10_1155_2024_1370364 crossref_primary_10_1038_leu_2016_10 crossref_primary_10_1016_j_ccell_2018_11_001 crossref_primary_10_1080_10428194_2024_2341151 crossref_primary_10_1182_bloodadvances_2019000237 crossref_primary_10_1038_s41467_019_09645_5 crossref_primary_10_1097_HS9_0000000000000959 |
Cites_doi | 10.1084/jem.194.11.1625 10.1182/blood-2012-01-402453 10.1182/blood-2010-05-284984 10.1038/nprot.2013.118 10.1038/ng.3413 10.1089/106652702761034136 10.1182/blood.V100.4.1410.h81602001410_1410_1416 10.1038/leu.2012.280 10.1111/j.1365-2141.2010.08299.x 10.1038/nature09906 10.1158/2159-8290.CD-13-0349 10.1182/blood-2014-02-555722 10.2217/epi.11.73 10.1038/nrc3486 10.1016/j.semcancer.2010.09.004 10.1016/j.ccell.2014.10.012 10.1182/blood-2011-06-357996 10.1038/nmeth.3115 10.1016/j.celrep.2014.06.053 10.1126/science.1242510 10.1038/ng.2443 10.1073/pnas.0810965105 10.1038/nature10113 10.1038/nature14192 10.1101/gr.103606.109 10.4049/jimmunol.181.5.3364 10.1038/bcj.2015.14 10.1016/0092-8674(94)90076-0 10.1016/j.stem.2014.07.005 10.1084/jem.188.9.1679 10.1182/blood-2006-11-056648 10.1093/bioinformatics/btp698 10.1084/jem.20101947 10.1038/nbt.1630 10.1038/nature12433 10.1016/S1074-7613(01)00085-1 10.1084/jem.20120833 10.1093/nar/gkt1323 10.1182/blood-2012-04-423517 10.1158/2159-8290.CD-14-0104 10.1182/blood-2006-12-062265 10.1016/S1074-7613(00)80040-0 10.1084/jem.185.3.563 10.1016/j.ccr.2012.08.024 10.1101/gr.155473.113 10.1038/leu.2014.252 10.4049/jimmunol.181.7.4590 10.1038/nature12787 10.1126/science.1256271 10.1016/j.exphem.2014.04.012 10.1016/j.cell.2013.01.019 10.1101/gr.152132.112 10.2217/epi.09.14 10.1073/pnas.1413374111 10.1038/leu.2012.245 10.1038/ng.3291 10.1093/bioinformatics/bts680 10.1073/pnas.0506580102 10.1126/science.1105136 10.1038/nrg3354 |
ContentType | Journal Article |
Copyright | Springer Nature America, Inc. 2015 COPYRIGHT 2016 Nature Publishing Group Copyright Nature Publishing Group Mar 2016 |
Copyright_xml | – notice: Springer Nature America, Inc. 2015 – notice: COPYRIGHT 2016 Nature Publishing Group – notice: Copyright Nature Publishing Group Mar 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QL 7QP 7QR 7SS 7T7 7TK 7TM 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7N M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 7T5 5PM |
DOI | 10.1038/ng.3488 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Opposing Viewpoints In Context Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Entomology Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic Immunology Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic Immunology Abstracts |
DatabaseTitleList | Genetics Abstracts Research Library Prep MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Agriculture Biology |
EISSN | 1546-1718 |
EndPage | 264 |
ExternalDocumentID | PMC4963005 3970892311 A446184741 26780610 10_1038_ng_3488 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: P01 CA081534 – fundername: NCI NIH HHS grantid: P01-CA81534 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29M 2FS 36B 39C 3O- 3V. 4.4 53G 5BI 5M7 5RE 5S5 70F 7X7 85S 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAEEF AAHBH AARCD AAYOK AAYZH AAZLF ABAWZ ABCQX ABDBF ABDPE ABEFU ABJNI ABLJU ABOCM ABTAH ABUWG ACBWK ACGFO ACGFS ACIWK ACMJI ACNCT ACPRK ACUHS ADBBV ADFRT AENEX AEUYN AFBBN AFFNX AFKRA AFRAH AFSHS AGAYW AGCDD AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 DWQXO EAD EAP EBC EBD EBS EE. EJD EMB EMK EMOBN EPL ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH GX1 HCIFZ HMCUK HVGLF HZ~ IAO IH2 IHR INH INR IOV ISR ITC L7B LGEZI LK8 LOTEE M0L M1P M2O M7P MVM N9A NADUK NNMJJ NXXTH ODYON P2P PKN PQQKQ PROAC PSQYO Q2X RIG RNS RNT RNTTT RVV SHXYY SIXXV SJN SNYQT SOJ SV3 TAOOD TBHMF TDRGL TN5 TSG TUS UKHRP VQA X7M XJT XOL Y6R YHZ ZGI ZXP ZY4 ~8M ~KM AAYXX ABFSG ACMFV ACSTC AETEA AFANA ALPWD ATHPR CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NFIDA NPM AEIIB PMFND 7QL 7QP 7QR 7SS 7T7 7TK 7TM 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N MBDVC P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 7X8 7T5 5PM |
ID | FETCH-LOGICAL-c734t-c7aa5f2b46514d13bc1bc5c0adf3fb8e7ba3a3d5904d55333033145706c578e93 |
IEDL.DBID | 7X7 |
ISSN | 1061-4036 1546-1718 |
IngestDate | Thu Aug 21 18:07:08 EDT 2025 Fri Jul 11 03:40:04 EDT 2025 Thu Jul 10 21:57:00 EDT 2025 Fri Jul 25 09:04:17 EDT 2025 Tue Jun 17 20:48:42 EDT 2025 Tue Jun 10 20:34:47 EDT 2025 Fri Jun 27 03:31:49 EDT 2025 Fri Jun 27 04:04:08 EDT 2025 Thu Apr 03 07:11:19 EDT 2025 Thu Apr 24 23:06:45 EDT 2025 Tue Jul 01 01:50:13 EDT 2025 Fri Feb 21 02:39:09 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Reprints and permissions information is available online at http://www.nature.com/reprints/index.html. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c734t-c7aa5f2b46514d13bc1bc5c0adf3fb8e7ba3a3d5904d55333033145706c578e93 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Present address: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA. |
ORCID | 0000-0003-2554-3952 |
OpenAccessLink | http://doi.org/10.1038/ng.3488 |
PMID | 26780610 |
PQID | 1770389453 |
PQPubID | 33429 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4963005 proquest_miscellaneous_1808740193 proquest_miscellaneous_1768167104 proquest_journals_1770389453 gale_infotracmisc_A446184741 gale_infotracacademiconefile_A446184741 gale_incontextgauss_ISR_A446184741 gale_incontextgauss_IOV_A446184741 pubmed_primary_26780610 crossref_citationtrail_10_1038_ng_3488 crossref_primary_10_1038_ng_3488 springer_journals_10_1038_ng_3488 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-03-01 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Nature genetics |
PublicationTitleAbbrev | Nat Genet |
PublicationTitleAlternate | Nat Genet |
PublicationYear | 2016 |
Publisher | Nature Publishing Group US Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group US – name: Nature Publishing Group |
References | Ernst (CR20) 2011; 473 Ferreira (CR29) 2014; 24 Kröber (CR51) 2002; 100 Kasowski (CR5) 2013; 342 Wang (CR17) 2013; 8 Klein (CR39) 2001; 194 Ziller (CR3) 2013; 500 Cabezas-Wallscheid (CR7) 2014; 15 Sturm (CR36) 2012; 22 Bibikova (CR53) 2009; 1 Bohle, Döring, Hansmann, Küppers (CR60) 2013; 27 Kretzmer (CR43) 2015; 47 Li, Durbin (CR52) 2010; 26 Florean, Schnekenburger, Grandjenette, Dicato, Diederich (CR22) 2011; 3 Rosén, Murray, Evaldsson, Rosenquist (CR49) 2010; 20 Pekarsky (CR50) 2008; 105 Teschendorff (CR55) 2013; 29 Andersson (CR1) 2014; 507 Lara-Astiaso (CR6) 2014; 345 Peng, Gerth, Ranger, Glimcher (CR46) 2001; 14 Kulis (CR15) 2015; 47 CR2 Shaknovich (CR18) 2011; 118 Cahill (CR12) 2013; 27 Queiros (CR11) 2015; 29 Puente (CR30) 2011; 475 Timp, Feinberg (CR9) 2013; 13 Landau (CR14) 2014; 26 Lai (CR19) 2013; 23 Schübeler (CR8) 2015; 517 Desper, Gascuel (CR58) 2002; 9 Oakes (CR13) 2014; 4 Pham (CR37) 2012; 119 Seifert (CR28) 2012; 209 Assenov (CR56) 2014; 11 Gustems (CR48) 2014; 42 Zhuang, Soriano, Weintraub (CR44) 1994; 79 Chen (CR41) 2008; 111 Kulis (CR10) 2012; 44 Reindl (CR34) 2010; 151 Zandi (CR26) 2008; 181 Klein, Rajewsky, Küppers (CR40) 1998; 188 Herishanu (CR32) 2011; 117 Landau (CR31) 2013; 152 Brocks (CR57) 2014; 8 Edelmann (CR35) 2012; 120 Heltemes-Harris (CR27) 2011; 208 Gururajan (CR45) 2008; 181 CR54 Smith, Meissner (CR4) 2013; 14 Mockridge (CR33) 2007; 109 Claus (CR25) 2014; 124 Dvinge (CR21) 2014; 111 Prange, Singh, Martens (CR42) 2014; 42 Teschendorff (CR23) 2010; 20 Smith (CR24) 2015; 5 McLean (CR61) 2010; 28 Subramanian (CR59) 2005; 102 Garrett-Sinha (CR47) 1999; 10 Damm (CR38) 2014; 4 Lebecque, de Bouteiller, Arpin, Banchereau, Liu (CR16) 1997; 185 AY Lai (BFng3488_CR19) 2013; 23 M Bibikova (BFng3488_CR53) 2009; 1 AE Teschendorff (BFng3488_CR23) 2010; 20 D Lara-Astiaso (BFng3488_CR6) 2014; 345 R Andersson (BFng3488_CR1) 2014; 507 D Sturm (BFng3488_CR36) 2012; 22 Q Wang (BFng3488_CR17) 2013; 8 XS Puente (BFng3488_CR30) 2011; 475 R Desper (BFng3488_CR58) 2002; 9 EN Smith (BFng3488_CR24) 2015; 5 Y Herishanu (BFng3488_CR32) 2011; 117 M Gururajan (BFng3488_CR45) 2008; 181 BFng3488_CR54 LA Garrett-Sinha (BFng3488_CR47) 1999; 10 D Brocks (BFng3488_CR57) 2014; 8 M Seifert (BFng3488_CR28) 2012; 209 A Rosén (BFng3488_CR49) 2010; 20 DA Landau (BFng3488_CR31) 2013; 152 AE Teschendorff (BFng3488_CR55) 2013; 29 A Subramanian (BFng3488_CR59) 2005; 102 CC Oakes (BFng3488_CR13) 2014; 4 AC Queiros (BFng3488_CR11) 2015; 29 U Klein (BFng3488_CR39) 2001; 194 PG Ferreira (BFng3488_CR29) 2014; 24 TH Pham (BFng3488_CR37) 2012; 119 SL Peng (BFng3488_CR46) 2001; 14 J Ernst (BFng3488_CR20) 2011; 473 M Kulis (BFng3488_CR10) 2012; 44 H Li (BFng3488_CR52) 2010; 26 S Lebecque (BFng3488_CR16) 1997; 185 Y Assenov (BFng3488_CR56) 2014; 11 DA Landau (BFng3488_CR14) 2014; 26 J Edelmann (BFng3488_CR35) 2012; 120 CI Mockridge (BFng3488_CR33) 2007; 109 A Kröber (BFng3488_CR51) 2002; 100 L Reindl (BFng3488_CR34) 2010; 151 BFng3488_CR2 LM Heltemes-Harris (BFng3488_CR27) 2011; 208 V Bohle (BFng3488_CR60) 2013; 27 R Claus (BFng3488_CR25) 2014; 124 KH Prange (BFng3488_CR42) 2014; 42 Y Zhuang (BFng3488_CR44) 1994; 79 H Kretzmer (BFng3488_CR43) 2015; 47 M Kasowski (BFng3488_CR5) 2013; 342 MJ Ziller (BFng3488_CR3) 2013; 500 Y Pekarsky (BFng3488_CR50) 2008; 105 H Dvinge (BFng3488_CR21) 2014; 111 L Chen (BFng3488_CR41) 2008; 111 CY McLean (BFng3488_CR61) 2010; 28 N Cabezas-Wallscheid (BFng3488_CR7) 2014; 15 M Kulis (BFng3488_CR15) 2015; 47 S Zandi (BFng3488_CR26) 2008; 181 W Timp (BFng3488_CR9) 2013; 13 R Shaknovich (BFng3488_CR18) 2011; 118 ZD Smith (BFng3488_CR4) 2013; 14 D Schübeler (BFng3488_CR8) 2015; 517 M Gustems (BFng3488_CR48) 2014; 42 U Klein (BFng3488_CR40) 1998; 188 N Cahill (BFng3488_CR12) 2013; 27 C Florean (BFng3488_CR22) 2011; 3 F Damm (BFng3488_CR38) 2014; 4 24071908 - Nat Protoc. 2013 Oct;8(10):2022-32 25103404 - Science. 2014 Aug 22;345(6199):943-9 18048647 - Blood. 2008 Mar 1;111(5):2685-92 20863893 - Semin Cancer Biol. 2010 Dec;20(6):400-9 25158935 - Cell Stem Cell. 2014 Oct 2;15(4):507-22 26437030 - Nat Genet. 2015 Nov;47(11):1316-25 17255355 - Blood. 2007 May 15;109(10):4424-31 24868078 - Blood. 2014 Jul 3;124(1):42-8 12149225 - Blood. 2002 Aug 15;100(4):1410-6 11163226 - Immunity. 2001 Jan;14(1):13-20 25151957 - Leukemia. 2015 Mar;29(3):598-605 9802980 - J Exp Med. 1998 Nov 2;188(9):1679-89 25385641 - Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16802-7 25262207 - Nat Methods. 2014 Nov;11(11):1138-40 23064414 - Nat Genet. 2012 Nov;44(11):1236-42 22922567 - Leukemia. 2013 Jan;27(1):150-8 20649559 - Br J Haematol. 2010 Oct;151(1):25-36 25860294 - Blood Cancer J. 2015 Apr 10;5:e303 24136358 - Science. 2013 Nov 8;342(6159):750-2 21642962 - Nature. 2011 Jun 05;475(7354):101-5 23175756 - Bioinformatics. 2013 Jan 15;29(2):189-96 23174882 - Leukemia. 2013 Mar;27(3):671-9 23925113 - Nature. 2013 Aug 22;500(7463):477-81 23400093 - Nat Rev Genet. 2013 Mar;14(3):204-20 24920063 - Cancer Discov. 2014 Sep;4(9):1088-101 20219944 - Genome Res. 2010 Apr;20(4):440-6 9053456 - J Exp Med. 1997 Feb 3;185(3):563-71 23760024 - Nat Rev Cancer. 2013 Jul;13(7):497-510 20940416 - Blood. 2011 Jan 13;117(2):563-74 26053498 - Nat Genet. 2015 Jul;47(7):746-56 19064921 - Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19643-8 16199517 - Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 21441907 - Nature. 2011 May 5;473(7345):43-9 23047824 - Blood. 2012 Dec 6;120(24):4783-94 18802061 - J Immunol. 2008 Oct 1;181(7):4590-602 21606506 - J Exp Med. 2011 Jun 6;208(6):1135-49 22550342 - Blood. 2012 Jun 14;119(24):e161-71 22122642 - Epigenomics. 2009 Oct;1(1):177-200 10229183 - Immunity. 1999 Apr;10(4):399-408 21828137 - Blood. 2011 Sep 29;118(13):3559-69 23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37 24371273 - Nucleic Acids Res. 2014 Mar;42(5):3059-72 24356097 - Cancer Discov. 2014 Mar;4(3):348-61 25693563 - Nature. 2015 Feb 19;518(7539):317-30 23415222 - Cell. 2013 Feb 14;152(4):714-26 25066126 - Cell Rep. 2014 Aug 7;8(3):798-806 23091163 - J Exp Med. 2012 Nov 19;209(12):2183-98 24814246 - Exp Hematol. 2014 Aug;42(8):637-50 12487758 - J Comput Biol. 2002;9(5):687-705 24013550 - Genome Res. 2013 Dec;23(12):2030-41 25490447 - Cancer Cell. 2014 Dec 8;26(6):813-25 15499007 - Science. 2004 Oct 22;306(5696):636-40 20436461 - Nat Biotechnol. 2010 May;28(5):495-501 11733577 - J Exp Med. 2001 Dec 3;194(11):1625-38 22126248 - Epigenomics. 2011 Oct;3(5):581-609 25592537 - Nature. 2015 Jan 15;517(7534):321-6 24265505 - Genome Res. 2014 Feb;24(2):212-26 24670763 - Nature. 2014 Mar 27;507(7493):455-61 20080505 - Bioinformatics. 2010 Mar 1;26(5):589-95 18714008 - J Immunol. 2008 Sep 1;181(5):3364-72 8001124 - Cell. 1994 Dec 2;79(5):875-84 |
References_xml | – volume: 194 start-page: 1625 year: 2001 end-page: 1638 ident: CR39 article-title: Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells publication-title: J. Exp. Med. doi: 10.1084/jem.194.11.1625 – volume: 119 start-page: e161 year: 2012 end-page: e171 ident: CR37 article-title: Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states publication-title: Blood doi: 10.1182/blood-2012-01-402453 – volume: 117 start-page: 563 year: 2011 end-page: 574 ident: CR32 article-title: The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2010-05-284984 – volume: 8 start-page: 2022 year: 2013 end-page: 2032 ident: CR17 article-title: Tagmentation-based whole-genome bisulfite sequencing publication-title: Nat. Protoc. doi: 10.1038/nprot.2013.118 – volume: 47 start-page: 1316 year: 2015 end-page: 1325 ident: CR43 article-title: DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control publication-title: Nat. Genet. doi: 10.1038/ng.3413 – volume: 9 start-page: 687 year: 2002 end-page: 705 ident: CR58 article-title: Fast and accurate phylogeny reconstruction algorithms based on the minimum-evolution principle publication-title: J. Comput. Biol. doi: 10.1089/106652702761034136 – volume: 100 start-page: 1410 year: 2002 end-page: 1416 ident: CR51 article-title: V mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V100.4.1410.h81602001410_1410_1416 – volume: 27 start-page: 671 year: 2013 end-page: 679 ident: CR60 article-title: Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma publication-title: Leukemia doi: 10.1038/leu.2012.280 – volume: 151 start-page: 25 year: 2010 end-page: 36 ident: CR34 article-title: Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms publication-title: Br. J. Haematol. doi: 10.1111/j.1365-2141.2010.08299.x – ident: CR54 – volume: 473 start-page: 43 year: 2011 end-page: 49 ident: CR20 article-title: Mapping and analysis of chromatin state dynamics in nine human cell types publication-title: Nature doi: 10.1038/nature09906 – volume: 4 start-page: 348 year: 2014 end-page: 361 ident: CR13 article-title: Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-13-0349 – volume: 124 start-page: 42 year: 2014 end-page: 48 ident: CR25 article-title: Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2014-02-555722 – volume: 3 start-page: 581 year: 2011 end-page: 609 ident: CR22 article-title: Epigenomics of leukemia: from mechanisms to therapeutic applications publication-title: Epigenomics doi: 10.2217/epi.11.73 – volume: 13 start-page: 497 year: 2013 end-page: 510 ident: CR9 article-title: Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3486 – volume: 20 start-page: 400 year: 2010 end-page: 409 ident: CR49 article-title: Antigens in chronic lymphocytic leukemia—implications for cell origin and leukemogenesis publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2010.09.004 – volume: 26 start-page: 813 year: 2014 end-page: 825 ident: CR14 article-title: Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia publication-title: Cancer Cell doi: 10.1016/j.ccell.2014.10.012 – volume: 118 start-page: 3559 year: 2011 end-page: 3569 ident: CR18 article-title: DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation publication-title: Blood doi: 10.1182/blood-2011-06-357996 – volume: 11 start-page: 1138 year: 2014 end-page: 1140 ident: CR56 article-title: Comprehensive analysis of DNA methylation data with RnBeads publication-title: Nat. Methods doi: 10.1038/nmeth.3115 – volume: 8 start-page: 798 year: 2014 end-page: 806 ident: CR57 article-title: Epigenetic intratumor heterogeneity and clonal evolution in aggressive prostate cancer publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.06.053 – volume: 102 start-page: 15545 year: 2005 end-page: 15550 ident: CR59 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl. Acad. Sci. USA – volume: 342 start-page: 750 year: 2013 end-page: 752 ident: CR5 article-title: Extensive variation in chromatin states across humans publication-title: Science doi: 10.1126/science.1242510 – volume: 44 start-page: 1236 year: 2012 end-page: 1242 ident: CR10 article-title: Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia publication-title: Nat. Genet. doi: 10.1038/ng.2443 – volume: 105 start-page: 19643 year: 2008 end-page: 19648 ident: CR50 article-title: Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0810965105 – volume: 475 start-page: 101 year: 2011 end-page: 105 ident: CR30 article-title: Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia publication-title: Nature doi: 10.1038/nature10113 – volume: 517 start-page: 321 year: 2015 end-page: 326 ident: CR8 article-title: Function and information content of DNA methylation publication-title: Nature doi: 10.1038/nature14192 – volume: 20 start-page: 440 year: 2010 end-page: 446 ident: CR23 article-title: Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer publication-title: Genome Res. doi: 10.1101/gr.103606.109 – volume: 181 start-page: 3364 year: 2008 end-page: 3372 ident: CR26 article-title: EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors publication-title: J. Immunol. doi: 10.4049/jimmunol.181.5.3364 – volume: 5 start-page: e303 year: 2015 ident: CR24 article-title: Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development publication-title: Blood Cancer J. doi: 10.1038/bcj.2015.14 – volume: 79 start-page: 875 year: 1994 end-page: 884 ident: CR44 article-title: The helix-loop-helix gene is required for B cell formation publication-title: Cell doi: 10.1016/0092-8674(94)90076-0 – volume: 15 start-page: 507 year: 2014 end-page: 522 ident: CR7 article-title: Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis publication-title: Cell Stem Cell doi: 10.1016/j.stem.2014.07.005 – volume: 188 start-page: 1679 year: 1998 end-page: 1689 ident: CR40 article-title: Human immunoglobulin (Ig)M IgD peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells publication-title: J. Exp. Med. doi: 10.1084/jem.188.9.1679 – volume: 109 start-page: 4424 year: 2007 end-page: 4431 ident: CR33 article-title: Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by V -gene mutational status publication-title: Blood doi: 10.1182/blood-2006-11-056648 – volume: 26 start-page: 589 year: 2010 end-page: 595 ident: CR52 article-title: Fast and accurate long-read alignment with Burrows-Wheeler transform publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp698 – volume: 208 start-page: 1135 year: 2011 end-page: 1149 ident: CR27 article-title: Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia publication-title: J. Exp. Med. doi: 10.1084/jem.20101947 – ident: CR2 – volume: 28 start-page: 495 year: 2010 end-page: 501 ident: CR61 article-title: GREAT improves functional interpretation of -regulatory regions publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1630 – volume: 500 start-page: 477 year: 2013 end-page: 481 ident: CR3 article-title: Charting a dynamic DNA methylation landscape of the human genome publication-title: Nature doi: 10.1038/nature12433 – volume: 14 start-page: 13 year: 2001 end-page: 20 ident: CR46 article-title: NFATc1 and NFATc2 together control both T and B cell activation and differentiation publication-title: Immunity doi: 10.1016/S1074-7613(01)00085-1 – volume: 209 start-page: 2183 year: 2012 end-page: 2198 ident: CR28 article-title: Cellular origin and pathophysiology of chronic lymphocytic leukemia publication-title: J. Exp. Med. doi: 10.1084/jem.20120833 – volume: 42 start-page: 3059 year: 2014 end-page: 3072 ident: CR48 article-title: c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifs publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkt1323 – volume: 120 start-page: 4783 year: 2012 end-page: 4794 ident: CR35 article-title: High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations publication-title: Blood doi: 10.1182/blood-2012-04-423517 – volume: 4 start-page: 1088 year: 2014 end-page: 1101 ident: CR38 article-title: Acquired initiating mutations in early hematopoietic cells of CLL patients publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-14-0104 – volume: 111 start-page: 2685 year: 2008 end-page: 2692 ident: CR41 article-title: ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2006-12-062265 – volume: 10 start-page: 399 year: 1999 end-page: 408 ident: CR47 article-title: PU.1 and Spi-B are required for normal B cell receptor–mediated signal transduction publication-title: Immunity doi: 10.1016/S1074-7613(00)80040-0 – volume: 185 start-page: 563 year: 1997 end-page: 571 ident: CR16 article-title: Germinal center founder cells display propensity for apoptosis before onset of somatic mutation publication-title: J. Exp. Med. doi: 10.1084/jem.185.3.563 – volume: 22 start-page: 425 year: 2012 end-page: 437 ident: CR36 article-title: Hotspot mutations in and define distinct epigenetic and biological subgroups of glioblastoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.08.024 – volume: 23 start-page: 2030 year: 2013 end-page: 2041 ident: CR19 article-title: DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation publication-title: Genome Res. doi: 10.1101/gr.155473.113 – volume: 29 start-page: 598 year: 2015 end-page: 605 ident: CR11 article-title: A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact publication-title: Leukemia doi: 10.1038/leu.2014.252 – volume: 181 start-page: 4590 year: 2008 end-page: 4602 ident: CR45 article-title: Early growth response genes regulate B cell development, proliferation, and immune response publication-title: J. Immunol. doi: 10.4049/jimmunol.181.7.4590 – volume: 507 start-page: 455 year: 2014 end-page: 461 ident: CR1 article-title: An atlas of active enhancers across human cell types and tissues publication-title: Nature doi: 10.1038/nature12787 – volume: 345 start-page: 943 year: 2014 end-page: 949 ident: CR6 article-title: Chromatin state dynamics during blood formation publication-title: Science doi: 10.1126/science.1256271 – volume: 42 start-page: 637 year: 2014 end-page: 650 ident: CR42 article-title: The genome-wide molecular signature of transcription factors in leukemia publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2014.04.012 – volume: 152 start-page: 714 year: 2013 end-page: 726 ident: CR31 article-title: Evolution and impact of subclonal mutations in chronic lymphocytic leukemia publication-title: Cell doi: 10.1016/j.cell.2013.01.019 – volume: 24 start-page: 212 year: 2014 end-page: 226 ident: CR29 article-title: Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia publication-title: Genome Res. doi: 10.1101/gr.152132.112 – volume: 1 start-page: 177 year: 2009 end-page: 200 ident: CR53 article-title: Genome-wide DNA methylation profiling using Infinium assay publication-title: Epigenomics doi: 10.2217/epi.09.14 – volume: 111 start-page: 16802 year: 2014 end-page: 16807 ident: CR21 article-title: Sample processing obscures cancer-specific alterations in leukemic transcriptomes publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1413374111 – volume: 14 start-page: 204 year: 2013 end-page: 220 ident: CR4 article-title: DNA methylation: roles in mammalian development publication-title: Nat. Rev. Genet. – volume: 27 start-page: 150 year: 2013 end-page: 158 ident: CR12 article-title: 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments publication-title: Leukemia doi: 10.1038/leu.2012.245 – volume: 47 start-page: 746 year: 2015 end-page: 756 ident: CR15 article-title: Whole-genome fingerprint of the DNA methylome during human B cell differentiation publication-title: Nat. Genet. doi: 10.1038/ng.3291 – volume: 29 start-page: 189 year: 2013 end-page: 196 ident: CR55 article-title: A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts680 – volume: 29 start-page: 598 year: 2015 ident: BFng3488_CR11 publication-title: Leukemia doi: 10.1038/leu.2014.252 – volume: 188 start-page: 1679 year: 1998 ident: BFng3488_CR40 publication-title: J. Exp. Med. doi: 10.1084/jem.188.9.1679 – volume: 475 start-page: 101 year: 2011 ident: BFng3488_CR30 publication-title: Nature doi: 10.1038/nature10113 – volume: 111 start-page: 2685 year: 2008 ident: BFng3488_CR41 publication-title: Blood doi: 10.1182/blood-2006-12-062265 – volume: 9 start-page: 687 year: 2002 ident: BFng3488_CR58 publication-title: J. Comput. Biol. doi: 10.1089/106652702761034136 – volume: 102 start-page: 15545 year: 2005 ident: BFng3488_CR59 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 15 start-page: 507 year: 2014 ident: BFng3488_CR7 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2014.07.005 – volume: 473 start-page: 43 year: 2011 ident: BFng3488_CR20 publication-title: Nature doi: 10.1038/nature09906 – volume: 27 start-page: 671 year: 2013 ident: BFng3488_CR60 publication-title: Leukemia doi: 10.1038/leu.2012.280 – volume: 13 start-page: 497 year: 2013 ident: BFng3488_CR9 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3486 – volume: 4 start-page: 1088 year: 2014 ident: BFng3488_CR38 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-14-0104 – volume: 5 start-page: e303 year: 2015 ident: BFng3488_CR24 publication-title: Blood Cancer J. doi: 10.1038/bcj.2015.14 – volume: 42 start-page: 637 year: 2014 ident: BFng3488_CR42 publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2014.04.012 – volume: 20 start-page: 400 year: 2010 ident: BFng3488_CR49 publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2010.09.004 – volume: 23 start-page: 2030 year: 2013 ident: BFng3488_CR19 publication-title: Genome Res. doi: 10.1101/gr.155473.113 – volume: 42 start-page: 3059 year: 2014 ident: BFng3488_CR48 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkt1323 – volume: 500 start-page: 477 year: 2013 ident: BFng3488_CR3 publication-title: Nature doi: 10.1038/nature12433 – volume: 117 start-page: 563 year: 2011 ident: BFng3488_CR32 publication-title: Blood doi: 10.1182/blood-2010-05-284984 – volume: 8 start-page: 2022 year: 2013 ident: BFng3488_CR17 publication-title: Nat. Protoc. doi: 10.1038/nprot.2013.118 – volume: 27 start-page: 150 year: 2013 ident: BFng3488_CR12 publication-title: Leukemia doi: 10.1038/leu.2012.245 – volume: 24 start-page: 212 year: 2014 ident: BFng3488_CR29 publication-title: Genome Res. doi: 10.1101/gr.152132.112 – volume: 47 start-page: 1316 year: 2015 ident: BFng3488_CR43 publication-title: Nat. Genet. doi: 10.1038/ng.3413 – volume: 29 start-page: 189 year: 2013 ident: BFng3488_CR55 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts680 – volume: 120 start-page: 4783 year: 2012 ident: BFng3488_CR35 publication-title: Blood doi: 10.1182/blood-2012-04-423517 – volume: 181 start-page: 4590 year: 2008 ident: BFng3488_CR45 publication-title: J. Immunol. doi: 10.4049/jimmunol.181.7.4590 – volume: 185 start-page: 563 year: 1997 ident: BFng3488_CR16 publication-title: J. Exp. Med. doi: 10.1084/jem.185.3.563 – volume: 3 start-page: 581 year: 2011 ident: BFng3488_CR22 publication-title: Epigenomics doi: 10.2217/epi.11.73 – volume: 8 start-page: 798 year: 2014 ident: BFng3488_CR57 publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.06.053 – ident: BFng3488_CR54 doi: 10.1126/science.1105136 – volume: 345 start-page: 943 year: 2014 ident: BFng3488_CR6 publication-title: Science doi: 10.1126/science.1256271 – volume: 209 start-page: 2183 year: 2012 ident: BFng3488_CR28 publication-title: J. Exp. Med. doi: 10.1084/jem.20120833 – ident: BFng3488_CR2 – volume: 26 start-page: 589 year: 2010 ident: BFng3488_CR52 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp698 – volume: 181 start-page: 3364 year: 2008 ident: BFng3488_CR26 publication-title: J. Immunol. doi: 10.4049/jimmunol.181.5.3364 – volume: 22 start-page: 425 year: 2012 ident: BFng3488_CR36 publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.08.024 – volume: 111 start-page: 16802 year: 2014 ident: BFng3488_CR21 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1413374111 – volume: 507 start-page: 455 year: 2014 ident: BFng3488_CR1 publication-title: Nature doi: 10.1038/nature12787 – volume: 10 start-page: 399 year: 1999 ident: BFng3488_CR47 publication-title: Immunity doi: 10.1016/S1074-7613(00)80040-0 – volume: 342 start-page: 750 year: 2013 ident: BFng3488_CR5 publication-title: Science doi: 10.1126/science.1242510 – volume: 47 start-page: 746 year: 2015 ident: BFng3488_CR15 publication-title: Nat. Genet. doi: 10.1038/ng.3291 – volume: 20 start-page: 440 year: 2010 ident: BFng3488_CR23 publication-title: Genome Res. doi: 10.1101/gr.103606.109 – volume: 517 start-page: 321 year: 2015 ident: BFng3488_CR8 publication-title: Nature doi: 10.1038/nature14192 – volume: 44 start-page: 1236 year: 2012 ident: BFng3488_CR10 publication-title: Nat. Genet. doi: 10.1038/ng.2443 – volume: 118 start-page: 3559 year: 2011 ident: BFng3488_CR18 publication-title: Blood doi: 10.1182/blood-2011-06-357996 – volume: 124 start-page: 42 year: 2014 ident: BFng3488_CR25 publication-title: Blood doi: 10.1182/blood-2014-02-555722 – volume: 105 start-page: 19643 year: 2008 ident: BFng3488_CR50 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0810965105 – volume: 1 start-page: 177 year: 2009 ident: BFng3488_CR53 publication-title: Epigenomics doi: 10.2217/epi.09.14 – volume: 11 start-page: 1138 year: 2014 ident: BFng3488_CR56 publication-title: Nat. Methods doi: 10.1038/nmeth.3115 – volume: 28 start-page: 495 year: 2010 ident: BFng3488_CR61 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1630 – volume: 4 start-page: 348 year: 2014 ident: BFng3488_CR13 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-13-0349 – volume: 208 start-page: 1135 year: 2011 ident: BFng3488_CR27 publication-title: J. Exp. Med. doi: 10.1084/jem.20101947 – volume: 194 start-page: 1625 year: 2001 ident: BFng3488_CR39 publication-title: J. Exp. Med. doi: 10.1084/jem.194.11.1625 – volume: 79 start-page: 875 year: 1994 ident: BFng3488_CR44 publication-title: Cell doi: 10.1016/0092-8674(94)90076-0 – volume: 119 start-page: e161 year: 2012 ident: BFng3488_CR37 publication-title: Blood doi: 10.1182/blood-2012-01-402453 – volume: 100 start-page: 1410 year: 2002 ident: BFng3488_CR51 publication-title: Blood doi: 10.1182/blood.V100.4.1410.h81602001410_1410_1416 – volume: 109 start-page: 4424 year: 2007 ident: BFng3488_CR33 publication-title: Blood doi: 10.1182/blood-2006-11-056648 – volume: 26 start-page: 813 year: 2014 ident: BFng3488_CR14 publication-title: Cancer Cell doi: 10.1016/j.ccell.2014.10.012 – volume: 152 start-page: 714 year: 2013 ident: BFng3488_CR31 publication-title: Cell doi: 10.1016/j.cell.2013.01.019 – volume: 14 start-page: 204 year: 2013 ident: BFng3488_CR4 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3354 – volume: 151 start-page: 25 year: 2010 ident: BFng3488_CR34 publication-title: Br. J. Haematol. doi: 10.1111/j.1365-2141.2010.08299.x – volume: 14 start-page: 13 year: 2001 ident: BFng3488_CR46 publication-title: Immunity doi: 10.1016/S1074-7613(01)00085-1 – reference: 11733577 - J Exp Med. 2001 Dec 3;194(11):1625-38 – reference: 24670763 - Nature. 2014 Mar 27;507(7493):455-61 – reference: 20080505 - Bioinformatics. 2010 Mar 1;26(5):589-95 – reference: 23174882 - Leukemia. 2013 Mar;27(3):671-9 – reference: 18714008 - J Immunol. 2008 Sep 1;181(5):3364-72 – reference: 20863893 - Semin Cancer Biol. 2010 Dec;20(6):400-9 – reference: 21606506 - J Exp Med. 2011 Jun 6;208(6):1135-49 – reference: 12149225 - Blood. 2002 Aug 15;100(4):1410-6 – reference: 8001124 - Cell. 1994 Dec 2;79(5):875-84 – reference: 10229183 - Immunity. 1999 Apr;10(4):399-408 – reference: 23064414 - Nat Genet. 2012 Nov;44(11):1236-42 – reference: 21441907 - Nature. 2011 May 5;473(7345):43-9 – reference: 22550342 - Blood. 2012 Jun 14;119(24):e161-71 – reference: 21642962 - Nature. 2011 Jun 05;475(7354):101-5 – reference: 25151957 - Leukemia. 2015 Mar;29(3):598-605 – reference: 24136358 - Science. 2013 Nov 8;342(6159):750-2 – reference: 26053498 - Nat Genet. 2015 Jul;47(7):746-56 – reference: 15499007 - Science. 2004 Oct 22;306(5696):636-40 – reference: 24013550 - Genome Res. 2013 Dec;23(12):2030-41 – reference: 23415222 - Cell. 2013 Feb 14;152(4):714-26 – reference: 24071908 - Nat Protoc. 2013 Oct;8(10):2022-32 – reference: 25592537 - Nature. 2015 Jan 15;517(7534):321-6 – reference: 23091163 - J Exp Med. 2012 Nov 19;209(12):2183-98 – reference: 25490447 - Cancer Cell. 2014 Dec 8;26(6):813-25 – reference: 25262207 - Nat Methods. 2014 Nov;11(11):1138-40 – reference: 9053456 - J Exp Med. 1997 Feb 3;185(3):563-71 – reference: 26437030 - Nat Genet. 2015 Nov;47(11):1316-25 – reference: 22922567 - Leukemia. 2013 Jan;27(1):150-8 – reference: 25693563 - Nature. 2015 Feb 19;518(7539):317-30 – reference: 23760024 - Nat Rev Cancer. 2013 Jul;13(7):497-510 – reference: 23175756 - Bioinformatics. 2013 Jan 15;29(2):189-96 – reference: 24371273 - Nucleic Acids Res. 2014 Mar;42(5):3059-72 – reference: 25103404 - Science. 2014 Aug 22;345(6199):943-9 – reference: 21828137 - Blood. 2011 Sep 29;118(13):3559-69 – reference: 19064921 - Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19643-8 – reference: 20436461 - Nat Biotechnol. 2010 May;28(5):495-501 – reference: 25860294 - Blood Cancer J. 2015 Apr 10;5:e303 – reference: 12487758 - J Comput Biol. 2002;9(5):687-705 – reference: 24920063 - Cancer Discov. 2014 Sep;4(9):1088-101 – reference: 20940416 - Blood. 2011 Jan 13;117(2):563-74 – reference: 22126248 - Epigenomics. 2011 Oct;3(5):581-609 – reference: 24868078 - Blood. 2014 Jul 3;124(1):42-8 – reference: 22122642 - Epigenomics. 2009 Oct;1(1):177-200 – reference: 23400093 - Nat Rev Genet. 2013 Mar;14(3):204-20 – reference: 25385641 - Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16802-7 – reference: 24265505 - Genome Res. 2014 Feb;24(2):212-26 – reference: 25066126 - Cell Rep. 2014 Aug 7;8(3):798-806 – reference: 24814246 - Exp Hematol. 2014 Aug;42(8):637-50 – reference: 23047824 - Blood. 2012 Dec 6;120(24):4783-94 – reference: 18802061 - J Immunol. 2008 Oct 1;181(7):4590-602 – reference: 17255355 - Blood. 2007 May 15;109(10):4424-31 – reference: 20649559 - Br J Haematol. 2010 Oct;151(1):25-36 – reference: 24356097 - Cancer Discov. 2014 Mar;4(3):348-61 – reference: 23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37 – reference: 25158935 - Cell Stem Cell. 2014 Oct 2;15(4):507-22 – reference: 23925113 - Nature. 2013 Aug 22;500(7463):477-81 – reference: 11163226 - Immunity. 2001 Jan;14(1):13-20 – reference: 20219944 - Genome Res. 2010 Apr;20(4):440-6 – reference: 9802980 - J Exp Med. 1998 Nov 2;188(9):1679-89 – reference: 16199517 - Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 – reference: 18048647 - Blood. 2008 Mar 1;111(5):2685-92 |
SSID | ssj0014408 |
Score | 2.6013083 |
Snippet | Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription... Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 253 |
SubjectTerms | 13/1 13/106 38/91 45/22 45/23 45/90 631/208/177 692/699/67/1990/283/1895 Adult Aged Aged, 80 and over Agriculture Animal Genetics and Genomics B cells B-Lymphocytes - immunology B-Lymphocytes - metabolism Binding Sites Biomedicine Cancer Cancer Research Chronic lymphocytic leukemia Consortia CpG Islands - genetics Deoxyribonucleic acid Development and progression Developmental stages DNA DNA methylation DNA Methylation - genetics Epigenesis, Genetic Epigenetic inheritance Epigenetics Female Gene expression Gene Expression Regulation, Leukemic Gene Expression Regulation, Neoplastic Gene Function Genetic aspects Genomes Growth Health aspects Human Genetics Humans Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - genetics Leukemia, Lymphocytic, Chronic, B-Cell - immunology Leukemia, Lymphocytic, Chronic, B-Cell - pathology Male Medical research Middle Aged Neoplasm Proteins - biosynthesis Neoplasm Proteins - genetics Phenotype Promoter Regions, Genetic Software Transcription factors Tumors |
Title | DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia |
URI | https://link.springer.com/article/10.1038/ng.3488 https://www.ncbi.nlm.nih.gov/pubmed/26780610 https://www.proquest.com/docview/1770389453 https://www.proquest.com/docview/1768167104 https://www.proquest.com/docview/1808740193 https://pubmed.ncbi.nlm.nih.gov/PMC4963005 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIvE98UxmQQgqewpLaT9Al1Y9NAoqDBUN8sf6VUrM5YmodK_PHcxWm2FLGXqJKvrWPf2Wff3e9HyGvhtLWiYJHWwkQ81XGk8iGPnDaCazAuJbDe-fMkPTnjn6Zi2l64VW1a5XpNbBZqWxq8I99Psgyx4Lhg7y9-R8gahdHVlkLjNtlG6DLU6mzaHbgwbhlK4VI8J2GYcieUmef7fvaO8YZu5Wo32lyTr21KmwmTG1HTZjM6vkd2Wi-SjsO03ye3nH9A7gReydVD8ufDZEyRG3oVMt2oDbzzFQ1VifSA4oU9XSCqZ5DAWrJL8Eepopi9Pvd1vaBlQdsADsVUsBLvays699QESF16vgJlKM1qiZ9d_cst5uoROTs--n54ErU0C5HJGF_CUylRDDWyonObMG0SmCgTK1uwQucu04opZsUo5laAdwibHku4yOLUgLm7EXtMtnzp3VNCc66R1MqCVTPuMoXQNHEaG2USllrNB-TNerilaTHIkQrjXDaxcJZLP5M4LwNCO8GLALvxr8grnC-JIBYes2Rmqq4q-fHLDzmGMy6cXMFZ-p_Qt9Oe0NtWqCihN9DbUJkA74TgWD3J3Z4kmKLpN691R7ZLQSWvFHdAXnbN-E1Mb_OurFEmzZMUnD1-g0weN_SJI_idJ0Edu6EZgssBSh4PSNZT1E4AQcT7LX7-swET5yMEXRPwv2uVvtb1_og_u_n1npO74E2mIUFvl2wtL2v3Ajy2pd5rzBKe-WGyR7YPjiZfT_8CgdVEBw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIQQvE990DDCIj6ewJLaT9AGhsjG1bCsSbNPegu04pdqajKURisTfxN_IXZx0SxF720sVyb-kjn0-n3N3vyPklTAqSUTKHKWEdnigXEdGPneM0oIrWFxSYL7z_jgYHvLPx-J4hfxpc2EwrLLVibWiTnKN38g3vTBELjgu2Ieznw5WjULvaltCw4rFrql-wZGteD_ahvl97fs7nw62hk5TVcDRIeNz-JVSpL7CIuA88ZjSHvRLuzJJWaoiEyrJJEtE3-WJAGMIdDzzuAjdQIN0GyRfApV_gzNYmpiZvrUIKUE_qU29C_Bchm7RNZvWHm1mk3eM1-VdLna_5T3g0ia4HKC55KWtN7-dO2StsVrpwIrZXbJisnvkpq1jWd0nv7fHA4q1qCsbWUcTW-e-oDYLkn6k6CCgM2QRtQjMXTsH-5dKitHy06wsZzRPaeMwohh6luP34YJOM6othS89rUD4cl3N8dqUJ2Y2lQ_I4bVMwEOymuWZeUxoxBUW0UpAizBuQolUOG7gaqk9FiSK98ibdrhj3XCeY-mN07j2vbMoziYxzkuP0AXwzNJ8_At5ifMVI2lGhlE5E1kWRTz6chQP4EwNJ2Uwzv4H-va1A3rbgNIcegO9tZkQ8E5IxtVBbnSQsPR1t7mVnbhRPUV8sVB65MWiGe_EcLrM5CVigsgLwLjkV2Aity7X2IfnPLLiuBgaH0wcEHK3R8KOoC4ASFrebcmmP2ryct5HkjcB_9uK9KWud0d8_erXe05uDQ_29-K90Xj3CbkNlmxggwM3yOr8vDRPwVqcq2f1EqXk-3XrhL9a2X3n |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIRAvE98UBhjEx1NoEttJ-oBQWalWBgUBm_YWbMcpFWsylkaoEn8Zfx13cZItRextL1UkX1LHPp_Pubvfj5CnwqgkESlzlBLa4YFyHRn53DFKC65gcUmB9c4fpsHuPn93KA43yJ-mFgbTKhubWBnqJNf4jbzvhSFiwXHB-mmdFvFpNH59_NNBBimMtDZ0GlZF9szqFxzfileTEcz1M98fv_26s-vUDAOODhlfwq-UIvUVEoLzxGNKe9BH7cokZamKTKgkkywRA5cnAhwjsPfM4yJ0Aw2abhCICcz_pZCFEa6xaKdNL8GYqS3DC_CMhiHSLVviHvWz2UvGK6qX051wfT84syGuJ2uuRWyrjXB8jWzVHiwdWpW7TjZMdoNctpyWq5vk92g6pMhLvbJZdjSxnPcFtRWR9A3FYAFdIKKolcA6thPwhamkmDk_z8pyQfOU1sEjimloOX4rLug8o9rC-dKjFShirldLvDblD7OYy1tk_0Im4DbZzPLM3CU04goJtRKwKIybUCIsjhu4WmqPBYniPfK8Ge5Y1_jnSMNxFFdxeBbF2SzGeekR2goeW8iPf0We4HzFCKCRoSrOZFkU8eTjQTyE8zWcmsFR-5_Ql88doRe1UJpDb6C3tioC3gmBuTqS2x1JMAO629zoTlyboSI-XTQ98rhtxjsxtS4zeYkyQeQF4Gjyc2Qit6JuHMBz7lh1bIfGB3cHlNztkbCjqK0AAph3W7L59wrInA8Q8E3A_zYqfabr3RG_d_7rPSJXwBrE7yfTvfvkKji1gc0T3Caby5PSPADHcakeViuUkm8XbRL-AjfWgh0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DNA+methylation+dynamics+during+B+cell+maturation+underlie+a+continuum+of+disease+phenotypes+in+chronic+lymphocytic+leukemia&rft.jtitle=Nature+genetics&rft.au=Oakes%2C+Christopher+C&rft.au=Seifert%2C+Marc&rft.au=Assenov%2C+Yassen&rft.au=Gu%2C+Lei&rft.date=2016-03-01&rft.pub=Nature+Publishing+Group&rft.issn=1061-4036&rft.eissn=1546-1718&rft.volume=48&rft.issue=3&rft.spage=253&rft_id=info:doi/10.1038%2Fng.3488&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3970892311 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1061-4036&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1061-4036&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1061-4036&client=summon |